Cargando…
Effects of Selective and Non-Selective Glucocorticoid Receptor II Antagonists on Rapid-Onset Diabetes in Young Rats
The blockade of glucocorticoid (GC) action through antagonism of the glucocorticoid receptor II (GRII) has been used to minimize the undesirable effects of chronically elevated GC levels. Mifepristone (RU486) is known to competitively block GRII action, but not exclusively, as it antagonizes the pro...
Autores principales: | Beaudry, Jacqueline L., Dunford, Emily C., Teich, Trevor, Zaharieva, Dessi, Hunt, Hazel, Belanoff, Joseph K., Riddell, Michael C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958344/ https://www.ncbi.nlm.nih.gov/pubmed/24642683 http://dx.doi.org/10.1371/journal.pone.0091248 |
Ejemplares similares
-
A rodent model of rapid-onset diabetes induced by glucocorticoids and high-fat feeding
por: Shpilberg, Yaniv, et al.
Publicado: (2012) -
Selective Glucocorticoid Receptor (GR-II) Antagonist Reduces Body Weight Gain in Mice
por: Asagami, Tomoko, et al.
Publicado: (2011) -
Prazosin Can Prevent Glucocorticoid Mediated Capillary Rarefaction
por: Mandel, Erin R., et al.
Publicado: (2016) -
The selective glucocorticoid receptor antagonist CORT125281 has tissue-specific activity
por: Koorneef, Lisa L, et al.
Publicado: (2020) -
Prevention of Exercise-Associated Dysglycemia: A Case Study–Based
Approach
por: Zaharieva, Dessi P., et al.
Publicado: (2015)